Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to -$8.3 million.

  • Anterix's Free Cash Flow fell 755.94% to -$8.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$26.6 million, marking a year-over-year decrease of 30033.09%. This contributed to the annual value of -$29.4 million for FY2025, which is 17040.73% down from last year.
  • Anterix's Free Cash Flow amounted to -$8.3 million in Q4 2025, which was down 755.94% from $1.4 million recorded in Q3 2025.
  • Anterix's Free Cash Flow's 5-year high stood at $39.6 million during Q4 2021, with a 5-year trough of -$16.6 million in Q1 2025.
  • Its 5-year average for Free Cash Flow is $25850.0, with a median of -$3.1 million in 2021.
  • As far as peak fluctuations go, Anterix's Free Cash Flow soared by 308268.21% in 2023, and later tumbled by 37214.75% in 2025.
  • Anterix's Free Cash Flow (Quarter) stood at $39.6 million in 2021, then tumbled by 102.84% to -$1.1 million in 2022, then skyrocketed by 3082.68% to $33.6 million in 2023, then plummeted by 122.92% to -$7.7 million in 2024, then fell by 7.56% to -$8.3 million in 2025.
  • Its Free Cash Flow was -$8.3 million in Q4 2025, compared to $1.4 million in Q3 2025 and -$3.1 million in Q2 2025.